Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddie Reed

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|March 12, 2011
Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implicationsArun Bhardwaj, Seema Singh, Sanjeev K Srivastava, et al.
Anticancer Research|March 14, 2013
β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cellsBaobo Zou, Q Quentin Li, Jinshun Zhao, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 26, 2012
Colorectal cancer screening practices in Alabama: a survey of primary care physiciansKathryn Chapman, Keith Nicholls, Margaret M Sullivan, et al.
International Journal of Oncology|December 25, 2013
GLI1 upregulates C-JUN through a specific 130-kDa isoformLauren Amable, Elaine Gavin, Kenji Kudo, et al.
Cancer Biology & Therapy|March 19, 2003
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomideYuichi Ando, Douglas K Price, William L Dahut, et al.
Molecular Pharmacology|January 19, 2007
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulvenTimothy Wiltshire, Jamie Senft, Yutian Wang, et al.
International Journal of Oncology|July 3, 2013
β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNKQuentin Q Li, Rebecca X Lee, Huasheng Liang, et al.
International Journal of Oncology|February 11, 2005
Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancerBujian Tang, Li Li, Zhifeng Jiang, et al.
Preventing Chronic Disease|November 3, 2005
When chronic conditions become acute: prevention and control of chronic diseases and adverse health outcomes during natural disastersAli H Mokdad, George A Mensah, Samuel F Posner, et al.
Anticancer Research|November 3, 2004
Down-regulation of cyclin E expression by caffeine promotes cancer cell entry into the S-phase of the cell cycleJichao Qin, Deding Tao, Xiaoxi Chen, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|March 12, 2011
Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implicationsArun Bhardwaj, Seema Singh, Sanjeev K Srivastava, et al.
Anticancer Research|March 14, 2013
β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cellsBaobo Zou, Q Quentin Li, Jinshun Zhao, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 26, 2012
Colorectal cancer screening practices in Alabama: a survey of primary care physiciansKathryn Chapman, Keith Nicholls, Margaret M Sullivan, et al.
International Journal of Oncology|December 25, 2013
GLI1 upregulates C-JUN through a specific 130-kDa isoformLauren Amable, Elaine Gavin, Kenji Kudo, et al.
Cancer Biology & Therapy|March 19, 2003
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomideYuichi Ando, Douglas K Price, William L Dahut, et al.
Molecular Pharmacology|January 19, 2007
BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulvenTimothy Wiltshire, Jamie Senft, Yutian Wang, et al.
International Journal of Oncology|July 3, 2013
β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNKQuentin Q Li, Rebecca X Lee, Huasheng Liang, et al.
International Journal of Oncology|February 11, 2005
Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancerBujian Tang, Li Li, Zhifeng Jiang, et al.
Preventing Chronic Disease|November 3, 2005
When chronic conditions become acute: prevention and control of chronic diseases and adverse health outcomes during natural disastersAli H Mokdad, George A Mensah, Samuel F Posner, et al.
Anticancer Research|November 3, 2004
Down-regulation of cyclin E expression by caffeine promotes cancer cell entry into the S-phase of the cell cycleJichao Qin, Deding Tao, Xiaoxi Chen, et al.
Pageof 9